Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01068301
What this trial is testing

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+2 more
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01383928
What this trial is testing

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 64
Early research (Phase 1)WithdrawnNCT07498465
What this trial is testing

Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more
Children's Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT06947967
What this trial is testing

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Who this might be right for
Lymphoma, T-Cell, Peripheral
Chipscreen Biosciences, Ltd. 224
Testing effectiveness (Phase 2)Study completedNCT01077622
What this trial is testing

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 10
Not applicableStudy completedNCT00854672
What this trial is testing

Muscle Strength and Exercise Capacity in Sarcoidosis Patients

Who this might be right for
Sarcoidosis
Maastricht University Medical Center 124
Not applicableStudy completedNCT06278181
What this trial is testing

Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon

Who this might be right for
MalariaDiabetes MellitusMetabolic Syndrome+1 more
Karolinska Institutet 406
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Testing effectiveness (Phase 2)Looking for participantsNCT06342466
What this trial is testing

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Who this might be right for
Systemic Amyloidosis
Jin Lu, MD 40
Testing effectiveness (Phase 2)Study completedNCT00035022
What this trial is testing

Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas

Who this might be right for
Leukemia, LymphocyticLymphoma
BioCryst Pharmaceuticals 71
Early research (Phase 1)Study completedNCT00871702
What this trial is testing

Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease

Who this might be right for
LeukemiaLymphoma, Non-HodgkinHodgkin Disease+2 more
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT06100237
What this trial is testing

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Who this might be right for
Multiple Myeloma
Carl Ola Landgren, MD, PhD 50
Testing effectiveness (Phase 2)UnknownNCT04877275
What this trial is testing

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Who this might be right for
Multiple Myeloma
Chunyan Sun, MD 50
Early research (Phase 1)Active Not RecruitingNCT06034470
What this trial is testing

Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms

Who this might be right for
Acute Myeloid LeukemiaMixed Phenotype Acute LeukemiaMyelodysplastic Syndrome+2 more
Fred Hutchinson Cancer Center 30
Not applicableStudy completedNCT00712556
What this trial is testing

PET Study in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 55
Early research (Phase 1)Study completedNCT05173545
What this trial is testing

Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects

Who this might be right for
Recurrent/Refractory Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00478075
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 50
Large-scale testing (Phase 3)Study completedNCT00270101
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Who this might be right for
AnemiaMultiple Myeloma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 156
Testing effectiveness (Phase 2)Looking for participantsNCT06580002
What this trial is testing

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric Cancer+19 more
University of California, Irvine 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04189757
What this trial is testing

Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
M.D. Anderson Cancer Center 9
Next Page